BioUtah News

Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors

LONDON and SALT LAKE CITY, July 03, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company to…
CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

Three separate teams of physician scientists at UCLA working on three different parts of the project have made…
Ultradent Adds New Cordless Prophy Handpiece

Ultradent Products, Inc. is announcing the addition of the Ultrapro™ Tx Cordless handpiece to its prestigious Ultrapro™ Tx…
CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks…
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray
CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment

UCLA research team has successfully created 7 pre-clinical monoclonal antibody candidates for targeting Ewing sarcoma
FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions

On June 13, the U.S. Food and Drug Administration (FDA) issued the final guidance: Content of Premarket Submissions…
Denali Therapeutics, Alucent Biomedical, Present to Utah Life Sciences Innovation Caucus

Utah legislators on Wednesday, June 14, held a meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at…
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

Recursion’s small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial…
Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and response
Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.

Acquisitions broaden Merit’s therapeutic platform with diverse dialysis product solutions and expand its access catheter offering Acquisitions projected…

Call to Action

Experience Seamless Style and Speed

Explore More

Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors

CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

Ultradent Adds New Cordless Prophy Handpiece

CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment

FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions

Denali Therapeutics, Alucent Biomedical, Present to Utah Life Sciences Innovation Caucus

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.

Call to Action

Post Category

Latest Posts

Social Links

SPECIAL THANKS TO OUR LEGACY & PLATINUM ELITE MEMBERS